Journals / Türkiye Diyabet ve Obezite Dergisi / 2019 / Cilt: 3 - Sayı: 3

Incidence of Helicobacter pylori Seropositivity in Turkish Pregnant Women with Gestational Diabetus Mellitus

Türk Toplumundaki Gestasyonel Diabetes Mellitus’lu Gebelerde Helicobacter pylori Seropozitivitesi Insidansı

Pages
149–153
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This data will be helpful for future studies that will investigate relation between HP seropositivity and pregnancy complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study to determine the Helicobacter pylori (HP) seropositivity in pregnant Turkish women and investigate the relationship with Gestational Diabetus Mellitus (GDM) with HP.
📊
Key Findings & Data:Material and Methods: A prospective case control study was conducted between September and November 2019 at Zonguldak Bulent Ecevit University, School of Medicine, Obstetrics and Gynecology Department.
💡
Conclusion & Impact:This data will be helpful for future studies that will investigate relation between HP seropositivity and pregnancy complications.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Gestasyonel diabetes mellitus · Gebelik · Helicobacter pylori

Abstract

Aim: The aim of this study to determine the Helicobacter pylori (HP) seropositivity in pregnant Turkish women and investigate the relationship with Gestational Diabetus Mellitus (GDM) with HP. Material and Methods: A prospective case control study was conducted between September and November 2019 at Zonguldak Bulent Ecevit University, School of Medicine, Obstetrics and Gynecology Department. Pregnant women who were 18-40 years old, at 26-37 weeks of gestational age and had singleton pregnancies included. Exclusion criteria were: Multiple pregnancy, pre-gestational diabetes mellitus, hypertension, hyperlipidemia, anemia and other systemic diseases. Study group was consisted of 46 women with diagnosed as GDM due to 75 gr oral glucose test and control group was consisted of 28 women. HP IgA ve IgG antibodies were measured using ELISA. Women were considered as HP (+) when IgA and/or IgG antibodies were positive, and considered as HP (-) when both antibodies were negative.Results: No difference were seen in maternal age, gravidity, parity, abortus, gestational age, ultrasonographic age, and estimated fetal weight between two groups. Body mass index, fasting blood glucose and fasting insulin levels, and HOMA-IR were significantly higher in GDM group than control group (p=0.018; p=<0.001; p=0.004; p=0.001 respectively). HP seropositivity were 77.3% in GDM group and 66.7% in control group but this difference was not statistically significant. HP IgG seropositivity was significantly higher in GDM group than control group (65.9% vs 31.8%, p=0,010). On the other hand HP IgA incidence was not different between two groups. Presence of both HP IgG and IgA seropositivity was higher in GDM group (28.2% vs 10.71%, GDM and control groups respectively, p= 0.008). Conclusion: Incidence of HP seropositivity and HP IgG seropositivity in Turkish pregnant women with GDM were higher than pregnant women without GDM, but statistical significance could not be established in aspect of HP seropositivity. This data will be helpful for future studies that will investigate relation between HP seropositivity and pregnancy complications.

Özet

Amaç: Bu çalışmanın amacı Türk toplumundaki gebe kadınlarında Helicobacter pylori (HP) seropozitivitesinin GDM ile ilişkisini araştırmaktır.

🔖

Cite This Article

ÖZMEN, Ü., HARMA, M., AKDEMİR, Y., DARKA, İ., HARMA, M. İ. (2022). Incidence of Helicobacter pylori Seropositivity in Turkish Pregnant Women with Gestational Diabetus Mellitus. Türkiye Diyabet ve Obezite Dergisi, Cilt: 3 - Sayı: 3, 149–153. https://ajindex.com/articles/627950

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868‐876
  2. Weyermann M, Rothenbacher D, Gayer L, Bode G, Adler G, Grab D, Flock F, Brenner H. Role of Helicobacter pylori infection in iron defciency during pregnancy. Am J Obstet Gynecol 2005; 192: 548-553 3. Kitagawa M, Natori M, Katoh M, Sugimoto K, Omi H, Akiyama Y, Sago H. Maternal transmission of Helicobacter pylori in the perinatal period. J Obstet Gynaecol Res 2001; 27: 225-230 4. Karaer A, Ozkan O, Ozer S, Bayir B, Kilic S, Babur C, Danişman N. Gastrointestinal symptoms and Helicobacter pylori infection in early pregnancy. A seroepidemiologic study. Gynecol Obstet Invest 2008; 66: 44-46 5. Berker B, Soylemez F, Cengiz SD, Kose SK. Serologic assay of Helicobacter pylori infection. Is it useful in hyperemesis gravidarum? J Reprod Med 2003; 48: 809-812 6. Bassily S, Frenck RW, Mohareb EW, Wierzba T, Savarino S, Hall E, Kotkat A, Nafcy A, Hyams KC, Clemens J. Seroprevalence of Helicobacter pylori among Egyptian newborns and their mothers: a preliminary report. Am J Trop Med Hyg 1999; 61: 37-40 7. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015
  3. Cardarapoli S, Rolfo A, Todros T. Helicobacter pylori and pregnancy related disorders. World J Gastroenterol 2014; 20(3):654-664
  4. Zhan Y, Si M, Li M, Jiang Y. The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systemic review and meta-analysis. Helicobacter. 2019; 24:e12562
  5. Göymen A, Özdurak İ, Özkaplan ŞE, Şimsek Y, Avcı F, Akpak YK. The relationship between the helicobacter pylori seropositivity with systemic and local oxidative status and hyperemesis gravidarum: a pilot study. J Matern Fetal Neonatal Med. 2018 May;31(9):1204-1208
  6. Bonfigli AR, Boemi M, Festa R, et al. Randomized, double‐blind, placebo‐controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2016;26(10):893‐898
  7. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic infammation and variation in genes encoding cytokines. Am J Cardiol. 2003;92(5):515–21
  8. Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysacchari